日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy

系统性免疫炎症指数在接受免疫疗法治疗的不可切除肝细胞癌患者中的预后价值

He, Tian; Xu, Bin; Wang, Lu-Na; Wang, Zi-Yi; Shi, Huan-Chen; Zhong, Cheng-Jie; Zhu, Xiao-Dong; Shen, Ying-Hao; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan; Hu, Bo; Huang, Cheng

Stable Disease without Tumor Shrink Cannot Benefit from Surgery following Immune-Based Therapy in Potentially Resectable Hepatocellular Carcinoma

对于潜在可切除的肝细胞癌,免疫治疗后病情稳定且肿瘤未缩小的患者无法从手术中获益。

He, Tian; Xu, Bin; Yang, Zi-Yue; Zhou, Shi-Qi; Wang, Zi-Yi; Wang, Lu-Na; Zhong, Cheng-Jie; Shi, Huan-Chen; Li, Hui; Hu, Bo; Zhu, Xiao-Dong; Shen, Ying-Hao; Gao, Qiang; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan; Huang, Cheng

CXCL6 Reshapes Lipid Metabolism and Induces Neutrophil Extracellular Trap Formation in Cholangiocarcinoma Progression and Immunotherapy Resistance.

CXCL6 重塑脂质代谢,诱导中性粒细胞胞外陷阱形成,从而导致胆管癌进展和免疫治疗耐药

He Tian, Wang Zi-Yi, Xu Bin, Zhong Cheng-Jie, Wang Lu-Na, Shi Huan-Chen, Yang Zi-Yue, Zhou Shi-Qi, Li Hui, Hu Bo, Zhu Xiao-Dong, Shen Ying-Hao, Zhou Jian, Fan Jia, Sun Hui-Chuan, Huang Cheng

Depth of Radiographic Response as an Independent Prognostic Factor for Patients with Initially Unresectable Hepatocellular Carcinoma Receiving Hepatectomy following Targeted Therapy plus Immunotherapy

放射学反应深度是接受靶向治疗联合免疫治疗后行肝切除术的初始不可切除肝细胞癌患者的独立预后因素

Xu, Bin; Wang, Lu-Na; Wang, Zi-Yi; He, Tian; Zhu, Xiao-Dong; Shen, Ying-Hao; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan; Huang, Cheng

Using CT features of cystic airspace to predict lung adenocarcinoma invasiveness

利用囊性气腔的CT特征预测肺腺癌的侵袭性

Zhang, Yu; Ding, Bo-Wen; Wang, Lu-Na; Ma, Wei-Ling; Zhu, Li; Chen, Qun-Hui; Yu, Hong